Page last updated: 2024-09-04

docetaxel anhydrous and Inflammatory Bowel Diseases

docetaxel anhydrous has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimi, A; Kato, J; Kuribayashi, K; Matsunaga, T; Murase, K; Niitsu, Y; Sakai, T; Sasaki, A; Satoh, M; Takimoto, R; Tateno, K; Terui, T; Wada, Y1

Other Studies

1 other study(ies) available for docetaxel anhydrous and Inflammatory Bowel Diseases

ArticleYear
A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer.
    Internal medicine (Tokyo, Japan), 2005, Volume: 44, Issue:5

    Topics: Aged; Alleles; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy; Carboplatin; Codon; DNA; Docetaxel; Drug Therapy, Combination; Female; Follow-Up Studies; Genes, p53; Germ-Line Mutation; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Mutation, Missense; Myelodysplastic Syndromes; Ovarian Neoplasms; Ovariectomy; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Skin; Taxoids

2005